Ali Amin
Papers
2
Total Citations
45
H-Index
2
About
Ali Amin is a urologic surgeon and researcher whose work bridges surgical innovation and molecular targeting in genitourinary cancers. His key research areas include minimally invasive urologic oncology, perioperative outcomes, and tumor-targeted drug delivery. Amin’s most influential work, a 2017 analysis of the National Surgical Quality Improvement Program comparing open versus minimally invasive partial nephrectomy, has garnered 37 citations and provided critical contemporary data on the comparative morbidity of these approaches, helping to guide surgical decision-making for renal tumors. In a more recent and novel contribution, Amin explored the use of pH Low Insertion Peptides (pHLIPs) to target bladder urothelial carcinoma, demonstrating successful delivery of imaging and therapeutic agents—specifically ICG and amanitin—to acidic tumor microenvironments. This work, cited 8 times, represents a promising step toward precision therapy for bladder cancer, addressing a significant unmet need. Amin’s research is characterized by its translational potential, from large-scale surgical outcomes analysis to cutting-edge molecular targeting, positioning him as a rising voice in urologic oncology with a focus on improving both surgical care and targeted therapeutics.
Research Focus
Key Achievements
Top Papers
- 1
- 2